JPRN-C000000207已完成3 期
Secondary prevention of HMG-CoA reductase inhibitor against stroke - Japan Statin Treatment Against Reccurent Stroke (J-STARS)
Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Sciences0 个研究点目标入组 3,000 人开始时间: 2005年9月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Ischemic stroke of other determined causea according to the TOAST classification 2) Ischemic heart disease necessary to require statin 3) Hemorrhagic disorders 4) Platelet count less than 100,000/ul within 3 months before study starts 5) Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) more than 100IU/L within 3 months prior to start of study 6) Serum creatinine more than 2.0mg/dl within 3 months prior to study 7) Any scheduled operations 8) The presence of malignant disorder 9) The patients participated in another clinical trial 10) The patient considered being unsuitable for the participation to the study by the medical doctor's judgment
研究者
相似试验
已完成
不适用
Prevention by HMGCoA reductase inhibition of Acute Lung Injury (ALI) associated with one lung ventilation following oesophagectomy by a reduction of pulmonary vascular dysfunction and inflammatioAcute Lung Injury (ALI)RespiratoryAcute lung InjuryISRCTN56543987The Royal Group of Hospitals Trust (UK)40
进行中（未招募）
1 期
Prevention by HMGCoA reductase inhibition of ALI associated with one lung ventilation following oesophagectomy by a Reduction of Pulmonary vascular dysfunction and inflammation (Prevention-HARP) - Acute lung injury post one lung ventilation; effects of simvastatiAcute lung injury (ALI)EUCTR2007-002454-37-GBThe Royal Group Hospitals Trust40
进行中（未招募）
1 期
Treatment with simvastatin of growth and bone abnormalities in children with Noonan syndromeEUCTR2016-000647-14-FRniversity Hospital Toulouse62
已完成
不适用
Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP)Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)RespiratoryAcute lung injury and acute respiratory distress syndrome (ARDS)ISRCTN70127774The Royal Group Hospitals Trust (UK)60
进行中（未招募）
不适用
A study to determine whether Simvastatin is of therapeutic value in patients with acute lung injury (ALI)Acute lung injuryEUCTR2010-020763-20-GBBelfast Health & Social Care Trust